Epithalon vs Humanin
Research Verdict
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
Quick Answers
Which is better, Epithalon or Humanin?
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
What is the key difference between Epithalon and Humanin?
Epithalon targets telomerase activation for systemic longevity; humanin targets BAX-mediated apoptosis and mitochondrial stress - different aging mechanisms with different safety concerns (humanin has a cancer survival signal via BAX inhibition).
Evidence Comparison
Epithalon: all clinical data from the Khavinson group in St. Petersburg, no independent replication, no Western regulatory review. Humanin: published by multiple independent groups (Hashimoto 2001, Muzumdar 2009), strong mechanistic characterization, but animal-only efficacy data. Humanin has superior independent validation; neither has human efficacy trials.
Evidence Context Favoring Epithalon
Telomere biology and aging biomarker research, accepting single-group evidence limitations.
Evidence Context Favoring Humanin
Mitochondrial neuroprotection or stress-response research where independent multi-lab validation matters.
Side-by-Side Snapshot
| Evidence grade | Epithalon: Level C Humanin: Level D |
|---|---|
| Research status | Epithalon: Preclinical Humanin: Preclinical |
| Primary category | Epithalon: Anti-Aging & Longevity Humanin: Anti-Aging & Longevity |
| Cited studies | Epithalon: 2 Humanin: 3 |